ATryn
STN: BL 125284
Proper Name: Antithrombin (Recombinant)
Tradename: ATryn
Manufacturer: GTC Biotherapeutics, Inc., License # 1794
Indication:
- Antithrombin (Recombinant) is indicated for the prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients.
Product Information
Supporting Documents
- Supporting Documents older than three years - ATryn
- Approval History, Letters, Reviews and Related Documents - ATryn